The generation of cell-mediated immunity against intracellular infection in
volves the production of IL-12, a critical cytokine required for the develo
pment of Th1 responses. The biologic activities of IL-12 are mediated throu
gh a specific, high affinity IL-12R composed of an 1L-12R beta1/IL-12R beta
2 heterodimer, with the IL-12R beta2 chain involved in signaling via Stat4.
We investigated IL-12R expression and function in human infectious disease
, using the clinical/immunologic spectrum of leprosy as a model. T cells fr
om tuberculoid patients, the resistant form of leprosy, are responsive to I
L-12; however, T cells from lepromatous patients, the susceptible form of l
eprosy, do not respond to IL-12. We found that the IL-12R beta2 was more hi
ghly expressed in tuberculoid lesions compared with lepromatous lesions. In
contrast, IL-12R beta1 expression was similar in both tuberculoid and lepr
omatous lesions. The expression of IL-12R beta2 on T cells was up-regulated
by Mycobacterium leprae in tuberculoid but not in lepromatous patients. Fu
rthermore, IL-12 induced Stat4 phosphorylation and DNA binding in M. leprae
-activated T cells from tuberculoid but not from lepromatous patients. Inte
restingly, IL-12R beta2 in lepromatous patients could be up-regulated by st
imulation with M. tuberculosis. These data suggest that Th response to M. l
eprae determines IL-12R beta2 expression and function in host defense in le
prosy.